US Medicare beneficiaries have no out-of-pocket expenses when receiving influenza vaccinations if the administering physician participates in the program, and there are no deductibles or coinsurance amounts to pay, yet this coverage was used by under 50% of Medicare's elderly enrollees in 1993, the first year of the immunization benefit.
Philip Pennington, vice president at Xact Medicare Services, says studies show up to 54% reductions in death rates for those receiving the shots, and project hundreds of millions of dollars saved in health care costs. In any year, 30 million Americans contract the flu virus, and 10,000-40,000 die as a result of complications.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze